Human melanocytes are not simply pigment-producing cells. It may be part of the inflammatory response, during which the pigmentary system may produce more melanin or suppress melanization. Toll-like receptors (TLRs) have been implicated in both innate host defense against pathogens and inflammatory response. Therefore, it may be possible that activation of TLRs in melanocytes may play a role in the modulation of melanogenesis. In this study, we investigated whether normal human melanocytes expressed TLRs and analyzed pigmentation changes upon TLR stimulation. The expression of TLR1∼10 mRNA in cultured human melanocyte was analyzed using RT-PCR, Western blotting and immunocytochemistry. Human melanocytes constitutively express mRNA and protein for TLR2, 3, 4, 5, 7, 9 and 10. Stimulation of TLR1/2 and 4 with Pam3CSK4 and lipopolysaccharide induced pigmentation of melanocytes. Activation of TLR5 and 7 with flagellin and imiquimod treatments reduced pigmentation of melanocytes and zebrafish. In summary, the results provided evidence for TLRs expression in normal human melanocytes. It is speculated that a response of melanocyte to TLR ligands may play a role in the pigmentary change in the skin. bridge, MA, USA), 5 (1:50; Santa Cruz Biotechnology), 7 (1:30; Abcam), 9 (1:50; Santa Cruz Biotechnology), and 10 (1:50; Santa Cruz Biotechnology), but not for TLR6 (1:50; Santa Cruz Biotechnology) in human melanocytes (Fig. 1B) . The expression of TLRs 2∼10 protein was further confirmed by Western blot analysis (Fig. 1C) . Cultured human melanocytes constitutively express mRNA and protein for TLR2, 3, 4, 5, 7, 9, and 10.
To investigate the functional role of TLRs in pigmentation, melanocytes were treated with Pam3CSK4 (InvivoGen, San Diego, CA, USA), polyinosinic-polycytidylic acid (PolyI:C; InvivoGen), LPS (Sigma Chemical Co., St. Louis, MO, USA), flagellin (InvivoGen) or imiquimod (InvivoGen), a ligand of TLR1/2, 3, 4, 5, or 7 for 5 days (Fig. 2A) . Addition of 10 μg/ml Pam3CSK4 or LPS increased melanin contents to 114 or 112% (mean±SD of control, n= 3, p＜0.05) of the control cells (100%), respectively. 
